ALS Limited
CPBLF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -4.79 | 0.38 | 2.66 |
| FCF Yield | 3.38% | 3.36% | 4.97% | 2.94% |
| EV / EBITDA | 14.71 | 21.13 | 12.38 | 14.81 |
| Quality | ||||
| ROIC | 8.71% | 1.57% | 15.13% | 8.90% |
| Gross Margin | 89.80% | 89.17% | 88.93% | 89.20% |
| Cash Conversion Ratio | – | – | 1.61 | 1.52 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.58% | 5.30% | 8.97% | 4.80% |
| Free Cash Flow Growth | 23.29% | -33.29% | 74.33% | -8.92% |
| Safety | ||||
| Net Debt / EBITDA | 2.96 | 4.44 | 2.16 | 2.39 |
| Interest Coverage | 5.39 | 6.86 | 14.41 | 9.56 |
| Efficiency | ||||
| Inventory Turnover | 2.35 | 2.46 | 2.49 | 3.20 |
| Cash Conversion Cycle | 33.64 | 61.89 | 55.62 | 53.14 |